Bevacizumab plus cisplatin/pemetrexed then bevacizumab alone for unresectable malignant pleural mesothelioma: A Japanese safety study

Takashi Nakano, Kozo Kuribayashi, Masashi Kondo, Masahiro Morise, Yuji Tada, Katsuya Hirano, Morihiko Hayashi, Misa Tanaka, Masataka Hirabayashi

Open source

DOI: 10.1111/ajco.13455
Published: 2020-09-07
Container: Asia-Pacific Journal of Clinical Oncology
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/ajco.13455,
  title = {Bevacizumab plus cisplatin/pemetrexed then bevacizumab alone for unresectable malignant pleural mesothelioma: A Japanese safety study},
  author = {Takashi Nakano and Kozo Kuribayashi and Masashi Kondo and Masahiro Morise and Yuji Tada and Katsuya Hirano and Morihiko Hayashi and Misa Tanaka and Masataka Hirabayashi},
  year = {2020},
  journal = {Asia-Pacific Journal of Clinical Oncology},
  doi = {10.1111/ajco.13455},
  url = {https://doi.org/10.1111/ajco.13455}
}

RIS

TY  - JOUR
TI  - Bevacizumab plus cisplatin/pemetrexed then bevacizumab alone for unresectable malignant pleural mesothelioma: A Japanese safety study
AU  - Takashi Nakano
AU  - Kozo Kuribayashi
AU  - Masashi Kondo
AU  - Masahiro Morise
AU  - Yuji Tada
AU  - Katsuya Hirano
AU  - Morihiko Hayashi
AU  - Misa Tanaka
AU  - Masataka Hirabayashi
PY  - 2020
JO  - Asia-Pacific Journal of Clinical Oncology
DO  - 10.1111/ajco.13455
UR  - https://doi.org/10.1111/ajco.13455
ER  -

APA

Nakano, T., Kuribayashi, K., Kondo, M., Morise, M., Tada, Y., Hirano, K., Hayashi, M., Tanaka, M., & Hirabayashi, M. (2020). Bevacizumab plus cisplatin/pemetrexed then bevacizumab alone for unresectable malignant pleural mesothelioma: A Japanese safety study. Asia-Pacific Journal of Clinical Oncology. https://doi.org/10.1111/ajco.13455

Source records

crossref · retrieved 2026-09-26T09:08:45.712Z